Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × zolbetuximab × Tumor-Agnostic × Clear all

Status

Recruiting 2 Completed 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Adenocarcinoma 1

Interventions

zolbetuximab 1 tempol 1 balstilimab 1 Peripheral Blood Stem Cell Transplantation 1 LY3023414 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06048081 2025-09-10

Early Access Program for Zolbetuximab

Astellas Pharma Inc

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡